Top Markets
#1 MowCat MowCat +49.01%
#2 Derive Derive +22.98%
#3 Audiera Audiera +21.36%
#4 Velvet Velvet +19.74%
#5 Biconomy Biconomy +17.74%
#6 Geodnet Geodnet +16.44%
#7 aPriori aPriori +13.80%
#8 Quack AI Quack AI +13.49%
#9 Cross Cross +13.44%
#10 Humanity Humanity +11.22%
Coin of the day
MowCat MowCat
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Clearmind Medicine Inc. Clearmind Medicine Inc.

Clearmind Medicine Inc.

CMND
Classement en actions #35565
Operating as a pre-clinical pharmaceutical firm, Clearmind Medicine Inc.... Operating as a pre-clinical pharmaceutical firm, Clearmind Medicine Inc. specializes in pioneering psychedelic therapies aimed at addressing overlooked medical conditions. Its development efforts encompass treatments for alcohol use disorders, notably binge drinking, various eating disorders, depression, and a spectrum of mental health challenges including binge eating and other compulsive behaviors. Founded in 2017, this Vancouver, Canada-based entity transitioned from its former identity as Cyntar Ventures Inc. to Clearmind Medicine Inc. in March 2021.
Prix de l'action
$1.17
Dernière synchronisation: 2024-03-14
Capitalisation boursière
$3.72M
Changement (1 jour)
-13.55%
Changement (1 an)
0.00%
Pays
CA
Échange Clearmind Medicine Inc. (CMND)

Catégorie

Healthcare
Ratio P/S pour Clearmind Medicine Inc. (CMND)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Clearmind Medicine Inc., le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour Clearmind Medicine Inc. de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE